Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a small maintenance update to the page's metadata. No substantive study content appears to be altered.
    Difference
    0.0%
    Check dated 2026-07-25T23:18:21.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the Study Details page. This change appears to be a version bump rather than a substantive modification of the page content.
    Difference
    0.0%
    Check dated 2026-07-04T09:22:21.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.0 to v3.6.2, with the older tag removed. This update seems to reflect a backend or template change rather than a user-facing content modification.
    Difference
    0.0%
    Check dated 2026-06-27T06:44:41.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    New navigation items and help sections were added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with a revision note to v3.6.0. The recruitment status now shows no longer looking for participants.
    Difference
    0.5%
    Check dated 2026-06-13T01:25:10.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Page revision label updated from v3.5.4 to v3.5.5, indicating a minor revision of the document. This change signals a version bump and does not modify the stated study details or eligibility information.
    Difference
    0.0%
    Check dated 2026-06-05T22:05:25.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    Sponsor for the MOR106 study is updated, switching the listed sponsor from Galapagos NV to Lakefront Biotherapeutics NV.
    Difference
    0.2%
    Check dated 2026-05-22T17:00:27.000Z thumbnail image

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.